Research - Los Angeles, California, United States
Nuravax is developing a wide spectrum of products based on its universal MultiTEP vaccine platform, a solution to most problems scientists face when working with CNS diseases. We have chosen to begin with Alzheimer's disease (AD) as the primary target. We created safe to elderly people vaccine with titer of antibodies high enough to penetrate Brain Blood Barrier and clear up pathological plagues, fibrils and oligomers without negative interference to normal activity of the brain.
Gmail
Dropbox
Mobile Friendly